首站-论文投稿智能助手
典型文献
SARS-CoV-2 receptor binding domain radio-probe:a non-invasive approach for angiotensin-converting enzyme 2 mapping in mice
文献摘要:
The spike protein of SARS-CoV-2 interacts with angiotensin-converting enzyme 2(ACE2)of human respiratory epithelial cells,which leads to infection.Furthermore,low-dose radiation has been found to reduce inflammation and aid the curing of COVID-19.The receptor binding domain(RBD),a recombinant spike protein with a His tag at the C-terminus,binds to ACE2 in human body.We thus constructed a radioiodinated RBD as a molecule-targeted probe to non-invasively explore ACE2 expression in vivo,and to investigate radiotherapy pathway for inhibiting ACE2.RBD was labeled with[124I]Nal using an N-bromosuccinimide(NBS)-mediated method,and 124I-RBD was obtained after purification with a specific activity of 28.9 GBq/nmol.Its radiochemical purity was(RCP)over 90%in saline for 5 days.The dissociation constant of 124I-RBD binding to hACE2 was 75.7 nM.The uptake of 124I-RBD by HeLaACE+cells at 2 h was 2.96%±0.35%,which could be substantially blocked by an excessive amount of RBD,and drop to 1.71%±0.23%.In BALB/c mice,the biodistribution of 124I-RBD after intravenous injection showed a moderate metabolism rate,and its 24 h-post injection(p.i.)organ distribution was similar to the expression profile in body.Micro-PET imaging of mice after intrapulmonary injection showed high uptake of lung at 1,4,24 h p.i..In conclusion,the experimental results demonstrate the potential of 124I-RBD as a novel targeted molecular probe for COVID-19.This probe may be used for non-invasive ACE2 mapping in mammals.
文献关键词:
作者姓名:
Dan Li;Jin Ding;Te-li Liu;Feng Wang;Xiang-xi Meng;Song Liu;Zhi Yang;Hua Zhu
作者机构:
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals(National Medical Products Administration),Department of Nuclear Medicine,Peking University Cancer Hospital&Institute,Beijing 100142,China
引用格式:
[1]Dan Li;Jin Ding;Te-li Liu;Feng Wang;Xiang-xi Meng;Song Liu;Zhi Yang;Hua Zhu-.SARS-CoV-2 receptor binding domain radio-probe:a non-invasive approach for angiotensin-converting enzyme 2 mapping in mice)[J].中国药理学报(英文版),2022(07):1749-1757
A类:
radioiodinated,124I,bromosuccinimide,HeLaACE+cells
B类:
SARS,CoV,receptor,binding,domain,probe,approach,angiotensin,converting,enzyme,mapping,mice,spike,protein,interacts,human,respiratory,epithelial,which,leads,infection,Furthermore,low,dose,radiation,has,been,found,reduce,inflammation,aid,curing,RBD,recombinant,His,tag,terminus,binds,body,We,thus,constructed,molecule,targeted,invasively,explore,expression,vivo,investigate,radiotherapy,pathway,inhibiting,was,labeled,Nal,using,NBS,mediated,method,obtained,after,purification,specific,activity,GBq,nmol,Its,radiochemical,purity,RCP,over,saline,days,dissociation,constant,hACE2,nM,uptake,by,could,substantially,blocked,excessive,amount,drop,In,BALB,biodistribution,intravenous,injection,showed,moderate,metabolism,its,post,organ,similar,profile,Micro,PET,imaging,intrapulmonary,high,lung,conclusion,experimental,results,demonstrate,potential,novel,molecular,This,may,used,mammals
AB值:
0.530861
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
FGF2 is overexpressed in asthma and promotes airway inflammation through the FGFR/MAPK/NF-κB pathway in airway epithelial cells
Yuan-Yang Tan;Hui-Qin Zhou;Yu-Jing Lin;Liu-Tong Yi;Zhuang-Gui Chen;Qing-Dong Cao;Yan-Rong Guo;Zhao-Ni Wang;Shou-Deng Chen;Yang Li;De-Yun Wang;Yong-Kang Qiao;Yan Yan-Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China;Department of Pathology,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China;Department of Pediatrics,the Third Affiliated Hospital,Sun Yat-Sen University,Guangzhou 510630,China;Department of Cardiothoracic Surgery,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China;Department of Otolaryngology,Yong Loo Lin School of Medicine,National University Health System,National University of Singapore,Singapore 119228,Singapore;BGI-Shenzhen,Shenzhen 518083,Guangdong,China;Central Laboratory,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China
An ultrapotent pan-β-coronavirus lineage B(β-CoV-B)neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope
Zezhong Liu;Wei Xu;Zhenguo Chen;Wangjun Fu;Wuqiang Zhan;Yidan Gao;Jie Zhou;Yunjiao Zhou;Jianbo Wu;Qian Wang;Xiang Zhang;Aihua Hao;Wei Wu;Qianqian Zhang;Yarning Li;Kaiyue Fan;Ruihong Chen;Qiaochu Jiang;Christian T.Mayer;Till Schoofs;Youhua Xie;Shibo Jiang;Yumei Wen;Zhenghong Yuan;Kang Wang;Lu Lu;Lei Sun;Qiao Wang-Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),School of Basic Medical Sciences;Shanghai Institute of Infectious Disease and Biosecurity;the Fifth People's Hospital of Shanghai;Shanghai Key Laboratory of Medical Epigenetics,International Co-laboratory of Medical Epigenetics and Metabolism(Ministry of Science and Technology);Institutes of Biomedical Sciences;Biosafety Level 3 Laboratory,Shanghai Medical College,Fudan University,Shanghai 200032,China;CAS Key Laboratory of Infection and Immunity,National Laboratory of Macromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;Experimental Immunology Branch,Center for Cancer Research,National Cancer Institute,National Institutes of Health,Bethesda,MD 20892,USA;GSK Vaccines,1300 Wavre,Belgium
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice,rabbits and NHPs
Zezhong Liu;Jie Zhou;Wei Xu;Wei Deng;Yanqun Wang;Meiyu Wang;Qian Wang;Ming Hsieh;Jingming Dong;Xinling Wang;Weijin Huangei;Lixiao Xing;Miaoling He;Chunlin Tao;Youhua Xie;Yilong Zhang;Youchun Wang;Jincun Zhao;Zhenghong Yuan;Chuan Qin;Shibo Jiang;Lu Lu-Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),School of Basic Medical Sciences;Shanghai Institute of Infectious Disease and Blosecurity;Biosafety Level 3 Laboratory,Shanghai Medical College,Shanghai Frontiers Science Center of Pathogenic Microbes and Infection,Fudan University,Shanghai,China;Key Laboratory of Human Disease Comparative Medicine,National Health Commission of the People's Republic of China;Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences and Comparative Medicine Center,Peking Union Medical College,Beijing,China;State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China;Institute of Infectious Disease,Guangzhou Eighth People's Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China;Guangzhou Laboratory,Bio-Island,Guangzhou,China;Graduate School of Peking Union Medical College,No.9 Dongdan Santiao,Dongcheng District,Beijing,China;Division of HIV/AIDS and Sex-transmitted Virus Vaccines,Institute for Biological Product Control,National Institutes for Food and Drug Control(NIFDC),No.31 Huatuo Street,Daxing District,Beijing,China;Fulgent Pharma LLC.,4978 Santa Anita Avenue,Temple City,CA,USA
Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
Jun Lan;Xinheng He;Yifei Ren;Ziyi Wang;Huan Zhou;Shilong Fan;Chenyou Zhu;Dongsheng Liu;Bin Shao;Tie-Yan Liu;Qisheng Wang;Linqi Zhang;Jiwan Ge;Tong Wang;Xinquan Wang-The Ministry of Education Key Laboratory of Protein Science,Beijing Advanced Innovation Center for Structural Biology,Beijing Frontier Research Center for Biological Structure,Collaborative Innovation Center for Biotherapy,School of Life Sciences,Tsinghua University,Beijing,China;Microsoft Research Asia,Beijing,China;Shanghai Synchrotron Radiation Facility,Shanghai Advanced Research Institute,Chinese Academy of Sciences,Shanghai,China;Department of Chemistry,Tsinghua University,Beijing,China;Center for Global Health and Infectious Diseases,Comprehensive AIDS Research Center,and Beijing Advanced Innovation Center for Structural Biology,School of Medicine,Tsinghua University,Beijing,China
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
Huan Ma;Xinghai Zhang;Peiyi Zheng;Peter H.Dube;Weihong Zeng;Shaohong Chen;Qingyu Cheng;Yunru Yang;Yan Wu;Junhui Zhou;Xiaowen Hu;Yan Xiang;Huajun Zhang;Sandra Chiu;Tengchuan Jin-Department of Pulmonary and Critical Care Medicine,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,Hubei,China;Laboratory of Structural Immunology,CAS Key Laboratory of Innate Immunity and Chronic Disease,Hefei National Laboratory for Physical Sciences at Microscale,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;Department of Microbiology,Immunology and Molecular Genetics,University of Texas Health Science Center at San Antonio,San Antonio,TX,USA;University of Chinese Academy of Sciences,Beijing,China;Institute of Health and Medicine,Hefei Comprehensive National Science Center,Hefei,Anhui,China
Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD—ACE2 complexes in living cells by competitive binding
Lu Miao;Wei Zhou;Chunyu Yan;Yuebin Zhang;Qinglong Qiao;Xuelian Zhou;Yingzhu Chen;Guangying Wang;Zhen-dong Guo;Jun Liu;Hailong Piao;Xia Pan;Mengxue Yan;Weijie Zhao;Guohui Li;Yueqing Li;Zhaochao Xu-CAS Key Laboratory of Separation Science for Analytical Chemistry,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;State Key Laboratory of Molecular Reaction Dynamics,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;Institute of Military Veterinary Science,The Academy of Military Medical Science of PLA,Changchun 130000,China;State Key Laboratory of Fine Chemicals,Department of Pharmaceutical Sciences,School of Chemical Engineering,Dalian University of Technology,Dalian 116024,China
Long-term correction of hemorrhagic diathesis in hemophilia A mice by an AAV-delivered hybrid FⅧ composed of the human heavy chain and the rat light chain
Jianhua Mao;Yun Wang;Wei Zhang;Yan Shen;Guowei Zhang;Wenda Xi;Qiang Wang;Zheng Ruan;Jin Wang;Xiaodong Xi-Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,Collaborative Innovation Center of Hematology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Shanghai Institute of Hematology,State Key Laboratory for Medical Genomics and Department of Hematology,Collaborative Innovation Center of Systems Biomedicine,P?le Sino-Fran?ais des Sciences du Vivant et Genomique,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Research Center for Experimental Medicine,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;The School of Medicine,Hangzhou Normal University,Hangzhou 310036,China;Shanghai Institute of Hypertension,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。